GZMA and fibrosis: Notably, GZMA was up-regulated in the bioinformatics analysis, where the samples of fibrosis were from kidney allograft rejection and hepatitis B liver fibrosis, both diseases that typically feature inflammation, while it was not altered in our samples which were specifically selected to minimize inflammation.